Cargando…

The Shinyanga Patient: A Patient’s Journey through HIV Treatment Cascade in Rural Tanzania

The 2016–2017 Tanzania HIV Impact Survey (THIS) reported the accomplishments towards the 90-90-90 global HIV targets at 61-94-87, affirming the need to focus on the first 90 (i.e., getting 90% of people living with HIV (PLHIV) tested). We conducted a patient-pathway analysis to understand the gap ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Okere, Nwanneka E, Sambu, Veryeh, Ndungile, Yudas, van Praag, Eric, Hermans, Sabine, Naniche, Denise, de Wit, Tobias F Rinke, Maokola, Werner, Gomez, Gabriela B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393654/
https://www.ncbi.nlm.nih.gov/pubmed/34444166
http://dx.doi.org/10.3390/ijerph18168418
_version_ 1783743775150964736
author Okere, Nwanneka E
Sambu, Veryeh
Ndungile, Yudas
van Praag, Eric
Hermans, Sabine
Naniche, Denise
de Wit, Tobias F Rinke
Maokola, Werner
Gomez, Gabriela B
author_facet Okere, Nwanneka E
Sambu, Veryeh
Ndungile, Yudas
van Praag, Eric
Hermans, Sabine
Naniche, Denise
de Wit, Tobias F Rinke
Maokola, Werner
Gomez, Gabriela B
author_sort Okere, Nwanneka E
collection PubMed
description The 2016–2017 Tanzania HIV Impact Survey (THIS) reported the accomplishments towards the 90-90-90 global HIV targets at 61-94-87, affirming the need to focus on the first 90 (i.e., getting 90% of people living with HIV (PLHIV) tested). We conducted a patient-pathway analysis to understand the gap observed, by assessing the alignment between where PLHIV seek healthcare and where HIV services are available in the Shinyanga region, Tanzania. We used existing and publicly available data from the National AIDS Control program, national surveys, registries, and relevant national reports. Region-wide, the majority (n = 458/722, 64%) of THIS respondents accessed their last HIV test at public sector facilities. There were 65.9%, 45.1%, and 74.1% who could also access antiretroviral therapy (ART), CD4 testing, and HIV viral load testing at the location of their last HIV test, respectively. In 2019, the viral suppression rate estimated among PLHIV on ART in the Shinyanga region was 91.5%. PLHIV access HIV testing mostly in public health facilities; our research shows that synergies can be achieved to improve access to services further down the cascade in this sector. Furthermore, effective engagement with the private sector (not-for-profit and for-profit) will help to achieve the last mile toward ending the HIV epidemic.
format Online
Article
Text
id pubmed-8393654
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83936542021-08-28 The Shinyanga Patient: A Patient’s Journey through HIV Treatment Cascade in Rural Tanzania Okere, Nwanneka E Sambu, Veryeh Ndungile, Yudas van Praag, Eric Hermans, Sabine Naniche, Denise de Wit, Tobias F Rinke Maokola, Werner Gomez, Gabriela B Int J Environ Res Public Health Article The 2016–2017 Tanzania HIV Impact Survey (THIS) reported the accomplishments towards the 90-90-90 global HIV targets at 61-94-87, affirming the need to focus on the first 90 (i.e., getting 90% of people living with HIV (PLHIV) tested). We conducted a patient-pathway analysis to understand the gap observed, by assessing the alignment between where PLHIV seek healthcare and where HIV services are available in the Shinyanga region, Tanzania. We used existing and publicly available data from the National AIDS Control program, national surveys, registries, and relevant national reports. Region-wide, the majority (n = 458/722, 64%) of THIS respondents accessed their last HIV test at public sector facilities. There were 65.9%, 45.1%, and 74.1% who could also access antiretroviral therapy (ART), CD4 testing, and HIV viral load testing at the location of their last HIV test, respectively. In 2019, the viral suppression rate estimated among PLHIV on ART in the Shinyanga region was 91.5%. PLHIV access HIV testing mostly in public health facilities; our research shows that synergies can be achieved to improve access to services further down the cascade in this sector. Furthermore, effective engagement with the private sector (not-for-profit and for-profit) will help to achieve the last mile toward ending the HIV epidemic. MDPI 2021-08-09 /pmc/articles/PMC8393654/ /pubmed/34444166 http://dx.doi.org/10.3390/ijerph18168418 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Okere, Nwanneka E
Sambu, Veryeh
Ndungile, Yudas
van Praag, Eric
Hermans, Sabine
Naniche, Denise
de Wit, Tobias F Rinke
Maokola, Werner
Gomez, Gabriela B
The Shinyanga Patient: A Patient’s Journey through HIV Treatment Cascade in Rural Tanzania
title The Shinyanga Patient: A Patient’s Journey through HIV Treatment Cascade in Rural Tanzania
title_full The Shinyanga Patient: A Patient’s Journey through HIV Treatment Cascade in Rural Tanzania
title_fullStr The Shinyanga Patient: A Patient’s Journey through HIV Treatment Cascade in Rural Tanzania
title_full_unstemmed The Shinyanga Patient: A Patient’s Journey through HIV Treatment Cascade in Rural Tanzania
title_short The Shinyanga Patient: A Patient’s Journey through HIV Treatment Cascade in Rural Tanzania
title_sort shinyanga patient: a patient’s journey through hiv treatment cascade in rural tanzania
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393654/
https://www.ncbi.nlm.nih.gov/pubmed/34444166
http://dx.doi.org/10.3390/ijerph18168418
work_keys_str_mv AT okerenwannekae theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT sambuveryeh theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT ndungileyudas theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT vanpraageric theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT hermanssabine theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT nanichedenise theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT dewittobiasfrinke theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT maokolawerner theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT gomezgabrielab theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT okerenwannekae shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT sambuveryeh shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT ndungileyudas shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT vanpraageric shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT hermanssabine shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT nanichedenise shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT dewittobiasfrinke shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT maokolawerner shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania
AT gomezgabrielab shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania